LOINC codes can significantly enhance cancer treatment by enabling personalized medicine. For example, standardized reporting of genetic mutations and biomarkers can help oncologists tailor treatment plans to the specific molecular profile of a patient's cancer. This is particularly important for therapies targeting specific mutations, such as targeted therapies and immunotherapies.
